Preethy, Senthilkumar
Aoki, Yoshitsugu
Minegishi, Katsura
Iwasaki, Masaru
Senthilkumar, Rajappa
Abraham, Samuel J. K.
Article History
Received: 18 April 2023
Accepted: 6 October 2023
First Online: 9 October 2023
Competing interests
: Author Samuel Abraham is a shareholder in GN Corporation, Japan which holds shares of Sophy Inc., Japan., the manufacturers of novel beta glucans using different strains of Aureobasidium pullulans; a board member in both the companies and also an applicant to several patents of relevance to these beta glucans. The remaining authors do not have any competing interests to disclose.